Introduced
Underlined text would be added to current law. Struck-through text would be removed.
| 89R1261 JG-F | ||
| By: Harrison | H.B. No. 855 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to promoting, prescribing, administering, or dispensing | |
| prescription drugs for off-label use. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. Subtitle A, Title 6, Health and Safety Code, is | |
| amended by adding Chapter 446 to read as follows: | |
| CHAPTER 446. OFF-LABEL USE OF PRESCRIPTION DRUGS | |
| Sec. 446.001. DEFINITIONS. In this chapter: | |
| (1) "Off-label use" means the use of a prescription | |
| drug approved for use by the United States Food and Drug | |
| Administration in a manner other than the approved use. | |
| (2) "Pharmacist" means a person licensed by the Texas | |
| State Board of Pharmacy to practice pharmacy. | |
| (3) "Physician" means an individual licensed by the | |
| Texas Medical Board to practice medicine in this state. | |
| Sec. 446.002. APPLICABILITY. This chapter applies only to | |
| the promoting, prescribing, administering, and dispensing of a | |
| prescription drug the United States Food and Drug Administration | |
| has approved for human use. | |
| Sec. 446.003. PROHIBITED DISCIPLINARY ACTION AGAINST | |
| PHYSICIAN'S OR PHARMACIST'S LICENSE. (a) Except as provided by | |
| Subsection (b), the state agency with licensing or regulatory | |
| authority over a physician or pharmacist may not revoke, fail to | |
| renew, suspend, or take any other adverse action against a | |
| physician's or pharmacist's license based solely on the physician | |
| or pharmacist: | |
| (1) prescribing, administering, or dispensing a | |
| prescription drug for off-label use to treat a patient; or | |
| (2) communicating or otherwise promoting to a patient | |
| an off-label use of a prescription drug. | |
| (b) The state agency with licensing or regulatory authority | |
| over a physician or pharmacist may revoke, fail to renew, suspend, | |
| or take any other adverse action against a physician's or | |
| pharmacist's license based on conduct described by Subsection | |
| (a)(1) or (2) if, after notice and hearing, the agency proves beyond | |
| a reasonable doubt that: | |
| (1) the conduct caused the physician's or pharmacist's | |
| patient to suffer physical harm; and | |
| (2) the initial onset of the patient's physical harm | |
| occurred not later than three years after the date of the | |
| physician's or pharmacist's conduct. | |
| SECTION 2. The changes in law made by this Act apply only to | |
| a prescription issued or a prescription drug promoted, | |
| administered, or dispensed on or after the effective date of this | |
| Act. | |
| SECTION 3. This Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.